MBX Biosciences, Inc. Common Stock (MBX) — Financial Flexibility Index
MBX Biosciences, Inc. Common Stock (MBX) has a Financial Flexibility Index of -1.32x as of March 2026. Free cash flow of $-19.77 Million (operating CF $-20.21 Million minus capex $437.00K) represents -1% of total liabilities ($14.95 Million). Check tangible equity quality of MBX Biosciences, Inc. Common Stock to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
MBX Biosciences, Inc. Common Stock Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for MBX Biosciences, Inc. Common Stock across 4 annual periods. For the full cash flow conversion analysis, see how efficiently does MBX Biosciences, Inc. Common Stock generate cash.
Annual Financial Flexibility Index for MBX Biosciences, Inc. Common Stock (2022–2025)
Year-by-year free cash flow to debt coverage for MBX Biosciences, Inc. Common Stock. Explore how well can MBX Biosciences, Inc. Common Stock service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.90x | $-78.02 Million | $-79.95 Million | $15.92 Million | ▼ -1.0% |
| 2024 | -4.85x | $-53.81 Million | $-54.68 Million | $11.09 Million | ▼ -2285.7% |
| 2023 | -0.20x | $-31.85 Million | $-31.98 Million | $156.65 Million | ▲ +21.4% |
| 2022 | -0.26x | $-22.68 Million | $-23.12 Million | $87.70 Million | — |